Phase II trial with sequential clofarabine and cyclophosphamide for refractory and relapsed philadelphia-negative adult acute lymphoblastic leukemia. Results of the GIMEMA LAL 1610 protocolRenato Bassan, Robin Foà, Francesca Paoloni et al.|Leukemia & lymphoma/Leukemia and lymphoma|2019Cited by 7